enteroscopy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) ASA level I-II; (2) Age 18-65 years old, regardless of gender; (3) BMI index between 24 and 32; (4) Voluntarily sign an informed consent form; (5) Those who undergo painless colonoscopy for the first time within 3 months and voluntarily take appropriate and effective contraceptive measures.
Exclusion criteria
Exclusion criteria: (1) The subject explicitly refused to participate in this study; (2) Individuals who are resistant to opioid drugs; (3) Individuals with sleep disorders or mental illnesses before enrollment; (4) Exposure to similar anesthetic drugs within 3 months; (5) Insufficiency of important organs such as heart function, liver function, kidney function, and lung function; (6) There were contraindications of propofol, sufentanil citrate and benzodiazepine in the enrolled patients; (7) Patients with a history of head injury, chest injury, intracranial surgery, or stroke within 4 weeks before surgery, or those with organic lesions of the central nervous system and consciousness disorders; (8) Hypertensive patients whose blood pressure has not been satisfactorily controlled after treatment with antihypertensive drugs (screening period sitting systolic blood pressure = 160mmHg, and/or screening period diastolic blood pressure = 105mmHg); (9) Pregnant or lactating women; (10) Other situations where participants in other clinical trials or researchers consider it inappropriate to enter the experiment within 3 months prior to surgery.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| injection pain;hypotension;hypertension;Decreased heart rate;Increased heart rate;apnea;Manually open airway;Kinetic reactionKinetic reaction;anaphylaxis;nausea and vomiting;Dizziness and headache;Drowsiness and fatigue;Abdominal pain and bloating;Patient satisfaction score; | — |
Primary
| Measure | Time frame |
|---|---|
| hypoxemia; | — |
Countries
China
Contacts
Deyang People's Hospital